To identify relevant studies, we will conduct a comprehensive search, in English and Chinese, of 10 electronic databases. The review will include randomised and quasi-randomised controlled trials that compare behavioural interventions (tailored and non-tailored) with/without the addition of pharmacotherapy with usual care, a minimal or placebo control for assisting expectant and new fathers to quit smoking and prevent smoking relapse. The primary outcome of interest is the self-reported and/or biochemically verified smoking abstinence at ≥1-month follow-up. Two reviewers will independently screen, select and extract relevant studies, and perform a quality assessment. Disagreements will be resolved by a consensus or third-party adjudication. The Cochrane Risk of Bias tool V.2 will be used to assess the risk of bias in the included studies. We will obtain the results of the systematic review through pooled quantitative analyses using a network meta-analysis. Sensitivity and subgroup analyses will be performed.
Ethical approval is not required for this systematic review of published data. The findings will be disseminated via peer-reviewed publication.
CRD42022340617.
方法:为了确定相关研究,我们将进行全面搜索,英语和汉语,10个电子数据库。审查将包括随机和准随机对照试验,比较行为干预(量身定制和非量身定制),有/没有增加药物治疗和常规护理。最小或安慰剂对照,用于帮助准父亲和新父亲戒烟并防止吸烟复发。感兴趣的主要结果是在≥1个月的随访中自我报告和/或生化验证的戒烟。两名审阅者将独立筛选,选择并提取相关研究,并进行质量评估。分歧将通过协商一致或第三方裁决解决。Cochrane偏差风险工具V.2将用于评估纳入研究的偏差风险。我们将使用网络荟萃分析通过汇总定量分析获得系统综述的结果。将进行敏感性和亚组分析。
背景:对已发表数据的系统评价不需要伦理批准。调查结果将通过同行评审的出版物传播。
■CRD4202234617。